Comparison of the Analgesic Efficacy of Transversalis Fascia Plane Block and Posterior Quadratus Lumborum Block in Pediatric Patient Undergoing Orchiopexy: A Prospective Observational Study
NCT ID: NCT07286799
Last Updated: 2025-12-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
54 participants
OBSERVATIONAL
2025-05-01
2025-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Children aged 1-7 years undergoing orchiopexy who received a transversalis fascia plane block.
Children aged 1-7 years undergoing orchiopexy who received a transversalis fascia plane block.
No interventions assigned to this group
Children Aged 1-7 Years Undergoing Orchiopexy Who Received a Posterior Quadratus Lumborum Block
Children Aged 1-7 Years Undergoing Orchiopexy Who Received a Posterior Quadratus Lumborum Block
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* History of prematurity (gestational age \< 37 weeks) Known coagulation disorders or bleeding tendency
* Infection, inflammation, or skin lesion at the injection site
* Known neurological or neuromuscular diseases
* Presence of significant cardiac or pulmonary disease (e.g., congenital heart disease, active asthma)
* Hepatic or renal dysfunction
* Known allergy or hypersensitivity to local anesthetics (e.g., bupivacaine, lidocaine)
* Developmental delay or cognitive impairment that prevents accurate pain assessment
* Use of additional regional analgesia techniques (e.g., caudal block) during surgery
* Block failure or intraoperative complications requiring exclusion from protocol analysis
* Lack of parental consent for participation in the study
1 Year
7 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Reyhan Kucuk Erturk
Resident Doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Prof. Dr. Cemil Taşcıoğlu Şehir Hastanesi
Istanbul, Şişli, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E-48670771-514.9900
Identifier Type: -
Identifier Source: org_study_id